Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMGN – Amgen Inc.

Amgen Inc.
AMGN
$290.33
Name : Amgen Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $156,112,175,104.00
EPSttm : 10.97
finviz dynamic chart for AMGN
Amgen Inc.
$290.33
1.13%
$3.23

Float Short %

2.68

Margin Of Safety %

8

Put/Call OI Ratio

0.87

EPS Next Q Diff

0.48

EPS Last/This Y

13.22

EPS This/Next Y

0.64

Price

290.5

Target Price

311.38

Analyst Recom

2.32

Performance Q

-10.63

Relative Volume

0.65

Beta

0.5

Ticker: AMGN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08AMGN272.050.851.03177033
2025-05-09AMGN265.760.861.08181353
2025-05-12AMGN274.620.870.57174522
2025-05-13AMGN269.850.830.90181216
2025-05-14AMGN262.150.840.63185087
2025-05-15AMGN271.60.830.35190071
2025-05-16AMGN272.40.841.01191257
2025-05-19AMGN275.830.930.85141361
2025-05-20AMGN275.050.930.40143950
2025-05-21AMGN271.280.901.42148636
2025-05-22AMGN271.930.910.57151707
2025-05-23AMGN271.890.891.91154360
2025-05-27AMGN279.310.890.31148865
2025-05-28AMGN278.520.821.60159432
2025-05-29AMGN283.540.850.39166185
2025-05-30AMGN287.810.840.49168105
2025-06-02AMGN288.50.820.85162299
2025-06-03AMGN289.580.830.40166217
2025-06-04AMGN287.030.833.66171147
2025-06-05AMGN287.120.860.95175249
2025-06-06AMGN290.350.871.09176732
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08AMGN272.006.15617.620.82
2025-05-09AMGN265.826.05513.520.79
2025-05-12AMGN274.766.06169.120.79
2025-05-13AMGN270.396.05715.220.79
2025-05-14AMGN262.246.05546.820.79
2025-05-15AMGN271.486.06309.120.79
2025-05-16AMGN272.536.05938.220.79
2025-05-19AMGN275.856.16050.020.81
2025-05-20AMGN275.055.75867.620.83
2025-05-21AMGN271.225.35740.120.83
2025-05-22AMGN271.935.35927.420.84
2025-05-23AMGN271.645.35890.720.84
2025-05-27AMGN279.455.36237.820.84
2025-05-28AMGN278.465.35860.120.84
2025-05-29AMGN283.595.36121.720.84
2025-05-30AMGN288.185.36095.720.84
2025-06-02AMGN288.505.35915.220.84
2025-06-03AMGN289.575.35947.320.84
2025-06-04AMGN286.975.35795.120.84
2025-06-05AMGN287.105.35905.720.84
2025-06-06AMGN290.505.36062.820.84
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08AMGN-5.910.152.71
2025-05-09AMGN-5.910.152.71
2025-05-12AMGN-6.701.572.72
2025-05-13AMGN-6.701.572.72
2025-05-14AMGN-6.701.572.72
2025-05-15AMGN-6.701.572.72
2025-05-16AMGN-6.701.572.72
2025-05-19AMGN-6.703.022.72
2025-05-20AMGN-6.413.022.72
2025-05-21AMGN-6.413.022.72
2025-05-22AMGN-6.413.022.72
2025-05-23AMGN-6.413.022.72
2025-05-27AMGN-6.411.892.72
2025-05-28AMGN-6.411.892.68
2025-05-29AMGN-6.411.892.68
2025-05-30AMGN-6.411.892.68
2025-06-02AMGN-6.412.372.68
2025-06-03AMGN-6.412.372.68
2025-06-04AMGN-6.412.372.68
2025-06-05AMGN-6.412.372.68
2025-06-06AMGN-6.412.372.68
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

4.9

Avg. EPS Est. Current Quarter

5.23

Avg. EPS Est. Next Quarter

5.38

Insider Transactions

-6.41

Institutional Transactions

2.37

Beta

0.5

Average Sales Estimate Current Quarter

8860

Average Sales Estimate Next Quarter

8920

Fair Value

312.62

Quality Score

85

Growth Score

91

Sentiment Score

64

Actual DrawDown %

16.3

Max Drawdown 5-Year %

-24.9

Target Price

311.38

P/E

26.5

Forward P/E

13.49

PEG

6.11

P/S

4.6

P/B

25.15

P/Free Cash Flow

14.3

EPS

10.95

Average EPS Est. Cur. Y​

20.84

EPS Next Y. (Est.)

21.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.49

Relative Volume

0.65

Return on Equity vs Sector %

71.5

Return on Equity vs Industry %

63.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

6062.8
Amgen Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 28000
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
stock quote shares AMGN – Amgen Inc. Stock Price stock today
news today AMGN – Amgen Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AMGN – Amgen Inc. yahoo finance google finance
stock history AMGN – Amgen Inc. invest stock market
stock prices AMGN premarket after hours
ticker AMGN fair value insiders trading